Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)	Edema, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, autonomic nervous system disorder, complex regional pain syndrome, complex regional pain syndrome type 1, nervous system disorder, neuromuscular disease, peripheral nervous system disorder	Recruiting	Phase 3	2026-09-10		NCT07210515

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Ambros Therapeutics, Inc.	3

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials